메뉴 건너뛰기




Volumn 31, Issue 1-2, 1998, Pages 89-104

Targeted delivery of chemotherapeutics: Tumor-activated prodrug therapy

Author keywords

Anti cancer agents; Antibody drug conjugates; Cancer; Prodrugs

Indexed keywords

ANTIBODIES; ONCOLOGY;

EID: 0032489812     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00095-1     Document Type: Review
Times cited : (232)

References (66)
  • 1
    • 0015462030 scopus 로고
    • Combination cancer therapy: Presidential address
    • Frei E. Combination cancer therapy: Presidential address. Cancer Res. 32:1972;2593-2607.
    • (1972) Cancer Res. , vol.32 , pp. 2593-2607
    • Frei, E.1
  • 2
    • 0016756272 scopus 로고
    • Continuous culture of fused cells secreting antibody of predefined specificity
    • Kohler G., Milstein C. Continuous culture of fused cells secreting antibody of predefined specificity. Nature. 256:1975;495-497.
    • (1975) Nature , vol.256 , pp. 495-497
    • Kohler, G.1    Milstein, C.2
  • 3
    • 0342832999 scopus 로고    scopus 로고
    • Improved oral drug delivery: Solubility limitations overcome by the use of prodrugs
    • Fleisher D., Bong R., Stewart B.H. Improved oral drug delivery: solubility limitations overcome by the use of prodrugs. Adv. Drug Deliv. Rev. 19:1996;115-130.
    • (1996) Adv. Drug Deliv. Rev. , vol.19 , pp. 115-130
    • Fleisher, D.1    Bong, R.2    Stewart, B.H.3
  • 4
    • 0343462226 scopus 로고    scopus 로고
    • Prodrugs and targeted drug delivery
    • Kearney A.S. Prodrugs and targeted drug delivery. Adv. Drug Deliv. Rev. 19:1996;225-239.
    • (1996) Adv. Drug Deliv. Rev. , vol.19 , pp. 225-239
    • Kearney, A.S.1
  • 6
    • 0010558895 scopus 로고
    • Tumor cell biology: Tumor specific and associated antigens
    • in: M.R. Zalutsky (Ed.) CRC, Boca Raton, FL
    • A.M. Carroll, M.I. Greene, Tumor cell biology: tumor specific and associated antigens, in: M.R. Zalutsky (Ed.), Antibodies in Radiodiagnosis and Therapy. CRC, Boca Raton, FL, 1989, pp. 13-43.
    • (1989) Antibodies in Radiodiagnosis and Therapy , pp. 13-43
    • Carroll, A.M.1    Greene, M.I.2
  • 11
    • 0026684815 scopus 로고
    • Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms
    • Yokota T., Milenic D.E., Whitlow M., Schlom J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 52:1992;3402-3408.
    • (1992) Cancer Res. , vol.52 , pp. 3402-3408
    • Yokota, T.1    Milenic, D.E.2    Whitlow, M.3    Schlom, J.4
  • 12
    • 0027249714 scopus 로고
    • Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms
    • Yokota T., Milenic D.E., Whitlow M., Wood J.F., Hubert S.L., Schlom J. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms. Cancer Res. 53:1993;3776-3783.
    • (1993) Cancer Res. , vol.53 , pp. 3776-3783
    • Yokota, T.1    Milenic, D.E.2    Whitlow, M.3    Wood, J.F.4    Hubert, S.L.5    Schlom, J.6
  • 14
    • 0001874124 scopus 로고
    • Epidermal growth factor and its receptor in human cancer
    • in: M. Sluyser (Ed.) VCH, Chichester
    • A.L. Harris, D. Neal, Epidermal growth factor and its receptor in human cancer, in: M. Sluyser (Ed.), Growth Factors and Oncogenes in Breast Cancer. VCH, Chichester, 1987, pp. 60-90.
    • (1987) Growth Factors and Oncogenes in Breast Cancer , pp. 60-90
    • Harris, A.L.1    Neal, D.2
  • 15
    • 0024998005 scopus 로고
    • The epidermal growth factor receptor as a target for therapy
    • Harris A.L. The epidermal growth factor receptor as a target for therapy. Cancer Cells. 2:1990;321-323.
    • (1990) Cancer Cells , vol.2 , pp. 321-323
    • Harris, A.L.1
  • 17
    • 0025647695 scopus 로고
    • Transforming growth factor-α
    • Massague J. Transforming growth factor-α J. Biol. Chem. 265:1990;21393-21396.
    • (1990) J. Biol. Chem. , vol.265 , pp. 21393-21396
    • Massague, J.1
  • 18
    • 0017767854 scopus 로고
    • Melanotropin-daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells
    • Varga J.M., Asato N., Lande S., Lerner A.B. Melanotropin-daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells. Nature. 267:1977;56-58.
    • (1977) Nature , vol.267 , pp. 56-58
    • Varga, J.M.1    Asato, N.2    Lande, S.3    Lerner, A.B.4
  • 19
    • 0021891363 scopus 로고
    • Hormone-drug conjugates
    • Academic Press
    • J.M. Varga, Hormone-drug conjugates, in: Methods in Enzymology, Academic Press 112, 1985, pp. 259-269.
    • (1985) in: Methods in Enzymology , vol.112 , pp. 259-269
    • Varga, J.M.1
  • 20
    • 0028002716 scopus 로고
    • Preparation and characterization of interleukin-2-gelonin conjugates made using different cross-linking reagents
    • McIntyre G.D., Scott C.F., Ritz J., Blättler W.A., Lambert J.M. Preparation and characterization of interleukin-2-gelonin conjugates made using different cross-linking reagents. Bioconjugate Chem. 5:1994;88-97.
    • (1994) Bioconjugate Chem. , vol.5 , pp. 88-97
    • McIntyre, G.D.1    Scott, C.F.2    Ritz, J.3    Blättler, W.A.4    Lambert, J.M.5
  • 22
    • 0023727121 scopus 로고
    • Biodistribution and tumor localization of a daunomycin-monoclonal antibody conjugate in nude mice with human tumor xenografts
    • Pimm M.V., Paul M.A., Ogumuyiwa Y., Baldwin R.W. Biodistribution and tumor localization of a daunomycin-monoclonal antibody conjugate in nude mice with human tumor xenografts. Cancer Immunol. Immunother. 27:1988;267-271.
    • (1988) Cancer Immunol. Immunother. , vol.27 , pp. 267-271
    • Pimm, M.V.1    Paul, M.A.2    Ogumuyiwa, Y.3    Baldwin, R.W.4
  • 23
    • 0023248720 scopus 로고
    • Disposition of the monoclonal antibody-Vinca alkaloid conjugate KS1/4-DAVLB (LY256787) and free 4-desacetylvinblastine (DAVLB) in tumor-bearing nude mice
    • Spearman M.E., Goodwin R.M., Apelgren L.D., Bumol T.F. Disposition of the monoclonal antibody-Vinca alkaloid conjugate KS1/4-DAVLB (LY256787) and free 4-desacetylvinblastine (DAVLB) in tumor-bearing nude mice. J. Pharmacol. Exp. Ther. 241:1987;695-703.
    • (1987) J. Pharmacol. Exp. Ther. , vol.241 , pp. 695-703
    • Spearman, M.E.1    Goodwin, R.M.2    Apelgren, L.D.3    Bumol, T.F.4
  • 24
    • 0021043785 scopus 로고
    • Enhanced anti-tumor activity of mitomycin C conjugated with anti-α-fetoprotein antibody by a novel method of conjugation
    • Kato Y., Tsukada Y., Hara T., Hirai H. Enhanced anti-tumor activity of mitomycin C conjugated with anti-α-fetoprotein antibody by a novel method of conjugation. J. Appl. Biochem. 5:1983;313.
    • (1983) J. Appl. Biochem. , vol.5 , pp. 313
    • Kato, Y.1    Tsukada, Y.2    Hara, T.3    Hirai, H.4
  • 25
    • 0027225273 scopus 로고
    • Immunochemotherapy of human colon carcinoma xenografts in nude mice using combinations of idarubicin-monoclonal antibody conjugates
    • Smyth M.J., Foster H.M., Andrew S.M., Teh J.G., Krauer K., McKenzie I.F.C., Pietersz G.A. Immunochemotherapy of human colon carcinoma xenografts in nude mice using combinations of idarubicin-monoclonal antibody conjugates. Immunol. Cell Biol. 71:1993;167-179.
    • (1993) Immunol. Cell Biol. , vol.71 , pp. 167-179
    • Smyth, M.J.1    Foster, H.M.2    Andrew, S.M.3    Teh, J.G.4    Krauer, K.5    McKenzie, I.F.C.6    Pietersz, G.A.7
  • 26
    • 0023152552 scopus 로고
    • Selective enhancement of anti-tumor activity of N-acetyl melphalan upon conjugation to monoclonal antibodies
    • Smyth M.J., Pietersz G.A., McKenzie I.F.C. Selective enhancement of anti-tumor activity of N-acetyl melphalan upon conjugation to monoclonal antibodies. Cancer Res. 47:1987;62-69.
    • (1987) Cancer Res. , vol.47 , pp. 62-69
    • Smyth, M.J.1    Pietersz, G.A.2    McKenzie, I.F.C.3
  • 27
    • 0028067743 scopus 로고
    • Antibody-targeted drugs for the therapy of cancer
    • Pietersz G.A., Krauer K. Antibody-targeted drugs for the therapy of cancer. J. Drug Targeting. 2:1994;183-215.
    • (1994) J. Drug Targeting , vol.2 , pp. 183-215
    • Pietersz, G.A.1    Krauer, K.2
  • 28
    • 0003046450 scopus 로고
    • Conjugates of antibodies with cytotoxic drugs
    • in: C.W. Vogel (Ed.) Oxford University Press, New York
    • M. Sela, E. Hurwitz, Conjugates of antibodies with cytotoxic drugs, in: C.W. Vogel (Ed.), Immunoconjugates, Oxford University Press, New York, 1987, pp. 189-216.
    • (1987) Immunoconjugates , pp. 189-216
    • Sela, M.1    Hurwitz, E.2
  • 29
    • 0025398273 scopus 로고
    • The linkage of cytotoxic drugs to antibodies for the treatment of cancer
    • Pietersz G.A. The linkage of cytotoxic drugs to antibodies for the treatment of cancer. Bioconjugate Chem. 1:1990;89-95.
    • (1990) Bioconjugate Chem. , vol.1 , pp. 89-95
    • Pietersz, G.A.1
  • 30
    • 0019170967 scopus 로고
    • Soluble macromolecules as carriers for daunorubicin
    • Hurwitz E., Wilchek M., Pitha J. Soluble macromolecules as carriers for daunorubicin. J. Appl. Biochem. 2:1980;25-35.
    • (1980) J. Appl. Biochem. , vol.2 , pp. 25-35
    • Hurwitz, E.1    Wilchek, M.2    Pitha, J.3
  • 31
    • 0023890683 scopus 로고
    • Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: Implications for future preparation of conjugates
    • Endo N., Takeda Y., Umemoto N., Kishida K., Watanabe K., Saito M., Kato Y., Hara T. Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates. Cancer Res. 48:1988;3330-3335.
    • (1988) Cancer Res. , vol.48 , pp. 3330-3335
    • Endo, N.1    Takeda, Y.2    Umemoto, N.3    Kishida, K.4    Watanabe, K.5    Saito, M.6    Kato, Y.7    Hara, T.8
  • 32
    • 0006052482 scopus 로고
    • A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: In vitro and in vivo studies
    • Trouet A., Masquelier M., Baurain R., Campeneere D.D.-D. A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies. Proc. Natl. Acad. Sci. USA. 79:1982;626-629.
    • (1982) Proc. Natl. Acad. Sci. USA , vol.79 , pp. 626-629
    • Trouet, A.1    Masquelier, M.2    Baurain, R.3    Campeneere, D.D.-D.4
  • 33
    • 0024557322 scopus 로고
    • Preparation and in vitro evaluation of a methotrexate-anti-MM46 monoclonal antibody conjugate via an oligopeptide spacer
    • Umemoto N., Kato Y., Endo N., Takeda Y., Hara T. Preparation and in vitro evaluation of a methotrexate-anti-MM46 monoclonal antibody conjugate via an oligopeptide spacer. Int. J. Cancer. 43:1989;677-684.
    • (1989) Int. J. Cancer , vol.43 , pp. 677-684
    • Umemoto, N.1    Kato, Y.2    Endo, N.3    Takeda, Y.4    Hara, T.5
  • 34
    • 0019786031 scopus 로고
    • Cis-Aconityl spacer between daunomycin and macromolecular carriers: A model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate
    • Shen W.-C., Ryser H.J.-P. cis-Aconityl spacer between daunomycin and macromolecular carriers: a model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate. Biochem. Biophys. Res. Commun. 102:1981;1048-1054.
    • (1981) Biochem. Biophys. Res. Commun. , vol.102 , pp. 1048-1054
    • Shen, W.-C.1    Ryser, H.J.-P.2
  • 35
    • 0023730095 scopus 로고
    • Pharmacokinetics and mechanism of action of a doxorubicin-monoclonal 9.2.27 conjugate directed to a human melanoma proteoglycan
    • Yang H.M., Reisfeld R.A. Pharmacokinetics and mechanism of action of a doxorubicin-monoclonal 9.2.27 conjugate directed to a human melanoma proteoglycan. J. Natl. Cancer Inst. 80:1988;1154-1157.
    • (1988) J. Natl. Cancer Inst. , vol.80 , pp. 1154-1157
    • Yang, H.M.1    Reisfeld, R.A.2
  • 36
    • 0023781775 scopus 로고
    • Superiority of an acid-labile daunorubicin-monoclonal antibody immunoconjugate compared to free drug
    • Dillman R.O., Johnson D.E., Shawler D.L., Koziol J.A. Superiority of an acid-labile daunorubicin-monoclonal antibody immunoconjugate compared to free drug. Cancer Res. 48:1988;6097-6102.
    • (1988) Cancer Res. , vol.48 , pp. 6097-6102
    • Dillman, R.O.1    Johnson, D.E.2    Shawler, D.L.3    Koziol, J.A.4
  • 39
    • 0023710359 scopus 로고
    • P-Benzylthiocarbamoyl-aspartyl-daunorubicin-substituted polytrisacryl. A new drug acid-labile arm-carrier conjugate
    • Daussin F., Boschetti E., Delmotte F., Monsigny M. p-Benzylthiocarbamoyl-aspartyl-daunorubicin-substituted polytrisacryl. A new drug acid-labile arm-carrier conjugate. Eur. J. Biochem. 176:1988;625-628.
    • (1988) Eur. J. Biochem. , vol.176 , pp. 625-628
    • Daussin, F.1    Boschetti, E.2    Delmotte, F.3    Monsigny, M.4
  • 40
    • 0026073686 scopus 로고
    • Inhibition of human renal cancer by monoclonal antibody-linked methotrexate in an ascites tumor model
    • Singh M., Ghose T., Kralovec J., Blair A.H., Belitsky P. Inhibition of human renal cancer by monoclonal antibody-linked methotrexate in an ascites tumor model. Cancer Immunol Immunother. 32:1991;331-334.
    • (1991) Cancer Immunol Immunother. , vol.32 , pp. 331-334
    • Singh, M.1    Ghose, T.2    Kralovec, J.3    Blair, A.H.4    Belitsky, P.5
  • 41
    • 0023583876 scopus 로고
    • Monoclonal antibody-drug conjugates for site-directed chemotherapy: Preclinical pharmacology and toxicology studies
    • Johnson I.S., Spearman M.E., Todd G.C., Zimmerman J.L., Bumol T.F. Monoclonal antibody-drug conjugates for site-directed chemotherapy: preclinical pharmacology and toxicology studies. Cancer Treatment Revs. 14:1987;193-196.
    • (1987) Cancer Treatment Revs. , vol.14 , pp. 193-196
    • Johnson, I.S.1    Spearman, M.E.2    Todd, G.C.3    Zimmerman, J.L.4    Bumol, T.F.5
  • 44
    • 0030050856 scopus 로고    scopus 로고
    • Preparation and functional evaluation of new doxorubicin immunoconjugates containing an acid-sensitive linker on small cell lung cancer
    • Froesch B.A., Stahel R.A. Preparation and functional evaluation of new doxorubicin immunoconjugates containing an acid-sensitive linker on small cell lung cancer. Cancer Immunol. Immunother. 42:1996;55-63.
    • (1996) Cancer Immunol. Immunother. , vol.42 , pp. 55-63
    • Froesch, B.A.1    Stahel, R.A.2
  • 46
    • 0021168147 scopus 로고
    • Tumor and tissue distribution of a methotrexate-anti-EL4 immunoglobulin conjugate in EL4 lymphoma-bearing mice
    • Uadia P., Blair A.H., Ghose T. Tumor and tissue distribution of a methotrexate-anti-EL4 immunoglobulin conjugate in EL4 lymphoma-bearing mice. Cancer Res. 44:1984;4263-4266.
    • (1984) Cancer Res. , vol.44 , pp. 4263-4266
    • Uadia, P.1    Blair, A.H.2    Ghose, T.3
  • 47
    • 0001577078 scopus 로고
    • Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude mice
    • Yang H.M., Reisfeld R.A. Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude mice. Proc. Natl. Acad. Sci. USA. 85:1988;1189-1193.
    • (1988) Proc. Natl. Acad. Sci. USA , vol.85 , pp. 1189-1193
    • Yang, H.M.1    Reisfeld, R.A.2
  • 48
    • 0025027766 scopus 로고
    • Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing
    • Braslawsky G.R., Edson M.A., Pearce W., Kaneko T., Greenfield R.S. Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing. Cancer Res. 50:1990;6608-6614.
    • (1990) Cancer Res. , vol.50 , pp. 6608-6614
    • Braslawsky, G.R.1    Edson, M.A.2    Pearce, W.3    Kaneko, T.4    Greenfield, R.S.5
  • 49
    • 0024323595 scopus 로고
    • Inhibition of human tumor growth in nude mice by a conjugate of doxorubicin with monoclonal antibody to epidermal growth factor receptor
    • Aboud-Pirak E., Hurwitz E., Bellot F., Schlessinger J., Sela M. Inhibition of human tumor growth in nude mice by a conjugate of doxorubicin with monoclonal antibody to epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA. 86:1989;3778-3781.
    • (1989) Proc. Natl. Acad. Sci. USA , vol.86 , pp. 3778-3781
    • Aboud-Pirak, E.1    Hurwitz, E.2    Bellot, F.3    Schlessinger, J.4    Sela, M.5
  • 50
    • 0024511770 scopus 로고
    • In vivo efficacy of monoclonal antibody-drug conjugates of three different subisotypes which bind the human tumor-associated antigen defined by the KS1/4 monoclonal antibody
    • Starling J.J., Maciak R.S., Hinson N.A., Nichols C.L., Briggs S.L., Laguzza B.C. In vivo efficacy of monoclonal antibody-drug conjugates of three different subisotypes which bind the human tumor-associated antigen defined by the KS1/4 monoclonal antibody. Cancer Immunol Immunother. 28:1989;171-178.
    • (1989) Cancer Immunol Immunother. , vol.28 , pp. 171-178
    • Starling, J.J.1    Maciak, R.S.2    Hinson, N.A.3    Nichols, C.L.4    Briggs, S.L.5    Laguzza, B.C.6
  • 51
    • 0025368366 scopus 로고
    • Antitumor activity of the monoclonal antibody-Vinca alkaloid immunoconjugate LY203725 (KS1/4-4-desacetylvinblastine-3-carboxhydrazide) in a nude mouse model of human ovarian cancer
    • Apelgren L.D., Zimmerman D.L., Bruggs S.L., Bumol T.F. Antitumor activity of the monoclonal antibody-Vinca alkaloid immunoconjugate LY203725 (KS1/4-4-desacetylvinblastine-3-carboxhydrazide) in a nude mouse model of human ovarian cancer. Cancer Res. 50:1990;3540-3544.
    • (1990) Cancer Res. , vol.50 , pp. 3540-3544
    • Apelgren, L.D.1    Zimmerman, D.L.2    Bruggs, S.L.3    Bumol, T.F.4
  • 52
    • 0025288274 scopus 로고
    • Phase I clinical comparative study of monoclonal antibody KS1/4 and KS1-4-methotrexate immunoconjugate in patients with non-small cell lung carcinoma
    • Elias D.J., Hirschowitz L., Kline L.E., Kroener J.F., Dillman R.O., Walker L.E., Robb J.A., Timms R.M. Phase I clinical comparative study of monoclonal antibody KS1/4 and KS1-4-methotrexate immunoconjugate in patients with non-small cell lung carcinoma. Cancer Res. 50:1990;4154-4159.
    • (1990) Cancer Res. , vol.50 , pp. 4154-4159
    • Elias, D.J.1    Hirschowitz, L.2    Kline, L.E.3    Kroener, J.F.4    Dillman, R.O.5    Walker, L.E.6    Robb, J.A.7    Timms, R.M.8
  • 61
    • 0027194197 scopus 로고
    • Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: A novel and potent family of antitumor antibiotics
    • Hinman L.M., Hamaan P.R., Wallace R., Menendez A.T., Durr F.E., Upeslacis J. Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics. Cancer Res. 53:1993;3536-3542.
    • (1993) Cancer Res. , vol.53 , pp. 3536-3542
    • Hinman, L.M.1    Hamaan, P.R.2    Wallace, R.3    Menendez, A.T.4    Durr, F.E.5    Upeslacis, J.6
  • 62
    • 0025491169 scopus 로고
    • Antibody conjugates with morpholinodoxorubicin and acid-cleavable linkers
    • Mueller B.M., Wrasidlo W.A., Reisfeld R.A. Antibody conjugates with morpholinodoxorubicin and acid-cleavable linkers. Bioconjugate Chem. 1:1990;325-330.
    • (1990) Bioconjugate Chem. , vol.1 , pp. 325-330
    • Mueller, B.M.1    Wrasidlo, W.A.2    Reisfeld, R.A.3
  • 63
    • 0016724870 scopus 로고
    • Antimitotic activity of the potent tumor inhibitor maytansine
    • Remillard S., Rebhun L.I., Howie G.A., Kupchan S.M. Antimitotic activity of the potent tumor inhibitor maytansine. Science. 189:1977;1002-1005.
    • (1977) Science , vol.189 , pp. 1002-1005
    • Remillard, S.1    Rebhun, L.I.2    Howie, G.A.3    Kupchan, S.M.4
  • 64
    • 0022586257 scopus 로고
    • The chemistry, mechanism of action and biological properties of CC-1065; A potent antitumor antibiotic
    • Reynolds V.L., McGovren J.P., Hurley L.H. The chemistry, mechanism of action and biological properties of CC-1065; a potent antitumor antibiotic. J. Antibiot. 39:1986;319-334.
    • (1986) J. Antibiot. , vol.39 , pp. 319-334
    • Reynolds, V.L.1    McGovren, J.P.2    Hurley, L.H.3
  • 65
    • 0001163468 scopus 로고
    • Calicheamicins: Discovery, structure, chemistry, and interaction with DNA
    • Lee M.D., Ellestad G.A., Borders D.B. Calicheamicins: discovery, structure, chemistry, and interaction with DNA. Acc. Chem. Res. 24:1991;235-243.
    • (1991) Acc. Chem. Res. , vol.24 , pp. 235-243
    • Lee, M.D.1    Ellestad, G.A.2    Borders, D.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.